UK markets open in 7 hours 22 minutes
  • NIKKEI 225

    28,608.59
    -909.71 (-3.08%)
     
  • HANG SENG

    28,013.81
    -581.89 (-2.03%)
     
  • CRUDE OIL

    65.48
    +0.20 (+0.31%)
     
  • GOLD FUTURES

    1,837.30
    +1.20 (+0.07%)
     
  • DOW

    34,269.16
    -473.66 (-1.36%)
     
  • BTC-GBP

    39,967.08
    +175.62 (+0.44%)
     
  • CMC Crypto 200

    1,513.93
    +1,271.26 (+523.84%)
     
  • ^IXIC

    13,389.43
    -12.43 (-0.09%)
     
  • ^FTAS

    3,962.98
    -97.82 (-2.41%)
     

HAEMATO AG proposes dividend payment

  • Oops!
    Something went wrong.
    Please try again later.
·2-min read
  • Oops!
    Something went wrong.
    Please try again later.

HAEMATO AG / Key word(s): Dividend/Payout
HAEMATO AG proposes dividend payment

04-May-2021 / 15:10 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Ad hoc of HAEMATO AG:

HAEMATO AG proposes dividend payment

The Supervisory Board of HAEMATO AG approved the Executive Board's proposal for the appropriation of profits at today's balance sheet meeting. The Executive Board and Supervisory Board will therefore propose a dividend of EUR 1.00 per dividend-bearing share at the Annual General Meeting to be held on July 13, 2021.

About HAEMATO:

HAEMATO AG, founded in 1993, is a pharmaceutical company. The focus of its business activities is on the trading of high-priced special pharmaceuticals (with a therapeutic focus on cancer, HIV and other chronic diseases) as well as the development and distribution of medical products and own brands, particularly in the field of "aesthetic medicine".

HAEMATO AG is listed on the Basic Board (Open Market) of the Frankfurt Stock Exchange.

Key figures of the HAEMATO AG share:

Subscribed capital: EUR 5,299,307

Listed share class: Ordinary bearer shares

ISIN: DE000A289VV1

WKN: A289VV

Stock exchange symbol: HAEK




Contact:
HAEMATO AG, Investor Relations
Telefon: +49 (0)30 897 30 86 70
ir@haemato.ag

04-May-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language:

English

Company:

HAEMATO AG

Lilienthalstraße 5c

12529 Schönefeld

Germany

Phone:

+49 (0)30 897 30 86 70

Fax:

+49 (0)30 897 30 86 79

E-mail:

ir@haemato.ag

Internet:

www.haemato.ag

ISIN:

DE000A289VV1

WKN:

A289VV

Listed:

Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Hamburg, Stuttgart, Tradegate Exchange

EQS News ID:

1192406


 

End of Announcement

DGAP News Service

show this
show this